Inceptive CEO Jakob Uszkoreit on Designing Medicines That Work Like Life Itself
Podcasts
•
21m
Inceptive CEO Jakob Uszkoreit goes Inside the ICE House to challenge the foundational assumptions of modern drug discovery, arguing that AI will enable medicines that work with the body's natural complexity rather than against it. He discusses Inceptive's partnership with Alnylam Pharmaceuticals and why their RNA interference platform and rich data history make them a uniquely powerful AI collaborator. Uszkoreit explains why partnerships are essential for a small company with broadly applicable technology, and why the long-term prize is therapies that are gentler, earlier, and truly personalized.
Up Next in Podcasts
-
8-27-2026: Nvidia Surge, Oil Relief +...
Eric Criscuolo, Market Strategist at the NYSE, recaps a week driven by three highly anticipated catalysts — PCE, Nvidia earnings, and Jackson Hole — following a quiet, range-bound start as markets awaited the key events. A breakthrough in Iran-Strait of Hormuz negotiations pulled oil sharply lowe...
-
Formation Bio CEO Ben Liu on Fixing t...
Formation Bio is rewriting the rules of drug development at a time when AI is accelerating drug discovery far faster than the industry can bring new therapies to patients. CEO Ben Liu goes Inside the ICE House to explain why the real bottleneck in pharma isn't finding promising drug candidates, i...
-
Horizon Head of Product Clark Allen
Clark Allen, Head of Product at Horizon Investments, joins Bilal Little on ETF Central to discuss the firm's rapid growth to more than $4 billion in ETF assets and its advisor-first approach to product development. Allen shares his journey from CPA and quantitative researcher to leading Horizon's...
